کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2817162 1159968 2013 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی ژنتیک
پیش نمایش صفحه اول مقاله
ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line
چکیده انگلیسی


• ERp57 binds specific DNA regions in a melanoma cell line.
• We studied the effect of ERp57 silencing on the target genes expression.
• We found other proteins interacting with the ERp57 target sequences.
• The protein APE/Ref-1 interacts with a specific ERp57 target region.

ERp57/PDIA3 is a ubiquitously expressed disulfide isomerase protein, which acts in concert with calreticulin and calnexin in the folding of glycoproteins destined to the plasma membrane or to be secreted. Its canonical compartment is the endoplasmic reticulum, where it acts as a chaperone and redox catalyst, but non canonical locations have been described as well, and ERp57 has been found associated with DNA and nuclear proteins. In previous work performed in HeLa cells, ERp57 has been demonstrated to bind specific DNA sequences involved in the stress response. The direct interaction with the DNA sequences identified as ERp57-targeted regions in HeLa cells has now been confirmed in a melanoma cell line. Furthermore, the ERp57 silencing, achieved by RNA interference, has produced a significant down-regulation of the expression of target genes. The possible involvement of other proteins in complex with ERp57 has been studied by an in vitro biotin–streptavidin based binding assay and the interacting protein APE/Ref-1 has been also assessed for its direct association with the ERp57 target regions. In conclusion, nuclear ERp57 interacts in vivo with DNA fragments in melanoma cells and is potentially involved in the transcriptional regulation of its target genes.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gene - Volume 524, Issue 2, 25 July 2013, Pages 390–395
نویسندگان
, , , , , ,